Search Results

1-8 of 8 results for askedby:"Patsy Calton"

Show detailed: On Off

Results: 10 20 50 100

Sort by: Newest first Oldest first

To ask the Secretary of State for Health, what assessment has been made by strategic health authorities of (a) the facilities available for drug maintenance and withdrawal, (b) the availability of licensed prescribers for heroin addicts and (c) the incidence of heroin use.

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

8 March 2004

Reference

153880; 418 c1329W;418 c1331W

House

House of Commons

Home Office

To ask the Secretary of State for the Home Department, what assessment he has made of the costs of criminal activity in connection with heroin use in each of the last five years. - Includes figures.

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Home Office

Type

Written questions

Status

Answered

Date

12 February 2004

Reference

417 c1716-7W;417 c1714-5W; 154829

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, how many and what proportion of patients use (a) animal and (b) GM-produced human insulin; what assessment has been made of the (i) likely changes in those figures over the next ten years and (ii) continuing availability of animal insulin; and if...

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Tabled on

17 November 2003

For answer on

20 November 2003

Answered on

20 November 2003

Mrs. Calton: To ask the Secretary of State for Health how many and what proportion of patients use (a) animal and (b) GM-produced human insulin; what assessment has been made of the (i) likely changes in those figures over the next 10 years and (ii) continuing availability of animal insulin; and if he will make a statement. [139904] Ms Rosie Winterton: Data on the number of people using animal and genetically modified produced human insulins are not collected and there has been no assessment or forecast made of the numbers of people likely to be using these insulins in the future. The table shows the number of prescription items that were dispensed in the community in England, and their cost, in the 12 months ended June 2003. Number of prescription items and net ingredient cost of insulins that were dispensed in the community in England for the 12 months ending June 2003 _________________________________________________________________________________________________. Number of prescription items (thousand) Net ingredient cost (£000) Highly purified animal insulin 128.1 4,217.2 Human sequence (GM insulin) 3,522.0 150,528.8 All insulins 3,650.0 154,746.0 _________________________________________________________________________________________________. Notes: 1. The data is from the Prescription Cost Analysis (PCA) system which covers all prescription items that are dispensed in the community in England. This does not include drugs dispensed in hospitals or private prescriptions. 2. Insulins are those defined in the British National Formulary (BNF) paragraph 6.1.1, "Insulins". Insulin drugs have been grouped into highly purified animal and human sequence (GM) insulin in line with the British National Formulary (BNF). 3. Doctors write prescriptions on a prescription form. Each single item written on the form is counted as a prescription item. The net ingredient cost refers to the cost (which the dispenser is reimbursed) of the drug before discounts and does not include any dispensing costs or fees.

Date

20 November 2003

Reference

139904; 413 c1390W;413 c1386W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what plans he has to require the disclosure of company drug trial results.

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

24 June 2003

Reference

119775; 407 c716W;407 c720W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what measures are in place to provide a multi-agency approach to treatment for those with alcohol dependency who also have mental health and other drug problems.

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Tabled on

12 June 2003

For answer on

18 June 2003

Answered on

18 June 2003

Mrs. Calton: To ask the Secretary of State for Health what measures are in place to provide a multi-agency approach to treatment for those with alcohol dependency who also have mental health and other drug problems. [119906] Miss Melanie Johnson: The Department of Health issued guidance last year on the management and delivery of effective treatment for adults with severe mental illness and co-existing drug or alcohol misuse problems. The guidance highlights the responsibilities of drug action teams and local implementation teams to work together locally in order to implement the guidance in accordance with local needs. The National Treatment Agency for substance misuse has also issued guidance in the last year for commissioners, `Models of Care'. The framework of this guidance applies to alcohol and drug treatment services and strongly supports the development of multi-agency approaches to treatment based on comprehensive assessment of needs, including for those with dual diagnoses. In addition, the National Institute for Mental Health in England is also working to identify how access to effective treatment can be improved and waiting times reduced. Many of the services affected by this work are joint drug and alcohol services. The Department of Health is preparing a new strategy on alcohol harm reduction which will set out a coherent and practical framework for a responsible approach which reinforces the message about sensible drinking and seeks to tackle alcohol misuse in all its forms. The NHS Plan said that we will be implementing the strategy by 2004, and we are on course to achieve that target. The Cabinet Office strategy unit is to undertake a project on alcohol misuse. Conclusions from the project will form the basis of the Government's alcohol strategy.

Date

18 June 2003

Reference

119906; 407 c274-5W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, what stocks of antibiotics have been made available for the treatment of infected populations in the event of a biological attack.

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

11 March 2003

Reference

99352; 401 c231-2W;401 c230W

House

House of Commons

Dept of Health

To ask the Secretary of State for Health, if he will make a statement on the availability of the Depo-Provera injection; what the effect is of the level of availability; and what steps his Department is taking in response.

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Department of Health

Type

Written questions

Status

Answered

Date

9 January 2003

Reference

88242; 397 c326W

House

House of Commons

Dept for Environment Food and Rural Affairs

To ask the Secretary of State for Environment, Food and Rural Affairs, how many and what type of (a) therapeutic and (b) non-therapeutic drugs were regularly given to chickens to prevent the spread of infection in the broiler chicken industry between 1995 and 2001. - The Veterinary Medicines Directorate does...

Asked by

Patsy Calton (Liberal Democrat)

Answering body

Department for Environment, Food and Rural Affairs

Type

Written questions

Status

Answered

Date

8 January 2002

Reference

377 c742W;377 c747-8W; 22928

House

House of Commons

Librarians' tools

Type

House

Session

Year

Department

Member

Primary member

Answering member

Legislative stage

Legislation

Subject

Publisher